Racheli Ofir
Chief Executive Officer bei Betalin Therapeutics Ltd.
Profil
Racheli Ofir is currently the Co-Chief Executive and Chief Technology Officer at Betalin Therapeutics Ltd.
Prior to this, she worked at Pluri, Inc. as the Vice President of Data and Intellectual Property from 2007 to 2022.
She holds a doctorate degree from both Technion-Israel Institute of Technology and Israel Institute of Technology.
Aktive Positionen von Racheli Ofir
| Unternehmen | Position | Beginn |
|---|---|---|
Betalin Therapeutics Ltd.
 Betalin Therapeutics Ltd. Packaged SoftwareTechnology Services Betalin Therapeutics Ltd. develops micro-pancreas and cell technology. The company is based in Jerusalem, Israel. The CEOs are Racheli Ofir, Moti Friedman. The Israeli company was founded in 2015 by Shuki Hershcovich. | Chief Executive Officer | 01.12.2022 |
Ehemalige bekannte Positionen von Racheli Ofir
| Unternehmen | Position | Ende |
|---|---|---|
| PLURI INC. | Chief Tech/Sci/R&D Officer | 01.05.2022 |
Ausbildung von Racheli Ofir
| Technion-Israel Institute of Technology | Doctorate Degree |
| Israel Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PLURI INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Betalin Therapeutics Ltd.
Betalin Therapeutics Ltd. Packaged SoftwareTechnology Services Betalin Therapeutics Ltd. develops micro-pancreas and cell technology. The company is based in Jerusalem, Israel. The CEOs are Racheli Ofir, Moti Friedman. The Israeli company was founded in 2015 by Shuki Hershcovich. | Technology Services |
